OakChart

Neogen Corp

NEOGHealthcare·Medical Devices·USA·Mid·NASD·Nov 11 • 3:59 PM ET

11.60-0.07 (-0.60%)
2026-11-12 03:36 CET
Market cap
2,532.35 USD m
Revenue, TTM
883.99 USD m
Net income, TTM
-56.12 USD m
Free cash flow, TTM
49.75 USD m
EPS diluted, TTM
-0.26
P/E
-
Compare

Price

NEOG against its 20, 50 and 200-day averages
2050200beat
8.0010.0012.0014.007.4M14.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NEOGclose 11.6020-day 11.9750-day 12.26200-day 10.5111.6052w high

18.7% under the 52-week high of 14.26 on 23 Sep 2026. 52-week low 5.37 on 21 Nov 2025. Last 15 sessions, 12.4% high to low

Volume 0.87× normal · the line is the 50-bar volume average

Profile

NEOG
52-week range, 70% of the way up
5.3714.26

Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

IndexRUT
Employees2636
IPOAug 23, 1989
Beta1.86
ATR, 14d0.53
Rel volume0.87
Short float5.88%
Insider own0.99%
Inst own110.19%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.53B
Enterprise Value3.13B
Income-56.12M
Sales883.99M
Book/sh9.56
Cash/sh0.79
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees2636
IPOAug 23, 1989

Ratios

P/E-
Forward P/E26.17
PEG1.12
P/S2.86
P/B1.21
P/C14.72
P/FCF50.90
EV/EBITDA26.64
EV/Sales3.55
Quick Ratio2.92
Current Ratio3.90
Debt/Eq0.37
LT Debt/Eq0.37
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.26
EPS next Y0.44
EPS next Q0.06
EPS this Y4.17%
EPS next Y33.00%
EPS next 5Y23.31%
EPS past 3/5Y33.08% -
Sales past 3/5Y1.91% 13.19%
EPS Y/Y TTM94.64%
Sales Y/Y TTM-0.33%
EPS Q/Q-132.66%
Sales Q/Q6.51%
EarningsOct 06 AMC
EPS/Sales Surpr.50.09% 7.03%

Ownership

Insider Own0.99%
Insider Trans-0.38%
Inst Own110.19%
Inst Trans2.68%
ROA-1.68%
ROE-2.67%
ROIC-1.96%
Gross Margin37.01%
Oper. Margin0.01%
Profit Margin-6.35%
SMA20-3.11%
SMA50-5.37%
SMA20010.42%
Trades-

Technical

Shs Outstand218.30M
Shs Float216.15M
Short Float5.88%
Short Ratio3.73
Short Interest12.71M
52W High14.26 -18.65%
52W Low5.37 116.01%
Volatility4.40% 4.05%
ATR (14)0.53
RSI (14)44.04
Beta1.86
Rel Volume0.87
Avg Volume3.41M
Volume2,959,229

Performance

Perf Week-6.90%
Perf Month-1.11%
Perf Quarter-2.44%
Perf Half Y33.49%
Perf YTD65.95%
Perf Year77.64%
Perf 3Y-23.18%
Perf 5Y-74.10%
Perf 10Y-49.64%
Recom1.60
Target Price14.00
Prev Close11.67
Price11.60
Change %-0.60%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 26, 2026UpgradePPiper SandlerNeutral → Overweight$14+20.7%
Jul 29, 2025DowngradeWWilliam BlairOutperform → Mkt Perform
Dec 19, 2024InitiatedGGuggenheimBuy$15+29.3%
Jun 16, 2023InitiatedWWells FargoOverweight$22+89.7%
Nov 22, 2022UpgradeWWilliam BlairMkt Perform → Outperform
Jul 12, 2022InitiatedPPiper SandlerNeutral$25+115.5%
May 23, 2019InitiatedGGuggenheimNeutral
Dec 05, 2017ResumedRROTH CapitalNeutral$82+606.9%
Jul 14, 2017InitiatedCCL KingNeutral
Jun 05, 2014InitiatedWWilliam BlairMkt Perform

Peers

Mkt cap
TickerCompanyMkt cap
BIOBio-Rad Laboratories Inc10.39B
IDXXIdexx Laboratories Inc55.35B
PAHCPhibro Animal Health Corp1.43B
TMOThermo Fisher Scientific Inc265.92B
AAgilent Technologies Inc49.89B
ELANElanco Animal Health Inc13.24B
ZTSZoetis Inc33.55B
MTDMettler-Toledo International Inc34.79B
WATWaters Corp46.27B
ECLEcolab Inc86.34B

Insider trading

latest 14 of 23
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Yarwood JeremyChief Scientific OfficerNov 03 '26Option Exercise11.8216,207191,56716,207Nov 04 04:10 PM
Yarwood JeremyChief Scientific OfficerNov 04 '26Sale12.679,051114,6760Nov 04 04:10 PM
Yarwood JeremyOfficerNov 04 '26Proposed Sale12.679,051114,637Nov 04 11:23 AM
Hastings Gregory SVP, Animal HealthOct 29 '26Option Exercise12.211,21114,78633,786Oct 30 03:33 PM
Woteki Catherine EDirectorOct 29 '26Option Exercise12.211,77621,68529,507Oct 30 03:08 PM
RODRIGUEZ RAFAEL ADirectorOct 29 '26Option Exercise12.211,77621,68531,211Oct 30 02:45 PM
Gupta AashimaDirectorOct 29 '26Option Exercise12.211,77621,68538,180Oct 30 06:47 AM
Green Ronald DDirectorOct 29 '26Option Exercise12.211,77621,68529,044Oct 30 06:43 AM
CAPELLO JEFFREY DDirectorOct 29 '26Option Exercise12.211,77621,68542,892Oct 30 06:39 AM
BOREL JAMES CDirectorOct 29 '26Option Exercise12.211,77621,685106,737Oct 30 06:34 AM
Bernard ThierryFormer DirectorOct 28 '26Proposed Sale12.1916,937206,521Oct 28 03:01 PM
Hastings Gregory SVP, Animal HealthOct 14 '26Option Exercise12.002873,44432,655Oct 23 06:55 AM
Nassif MikhealCEOOct 09 '26Buy11.955056,0351,579Oct 09 07:24 PM
Nassif MikhealCEOAug 04 '26Buy11.813704,3701,074Aug 06 08:16 AM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IJSiShares S&P Small-Cap 600 Value ETFAUM: 7.74B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-10-060.0800.053-0.050222.8208.183
2025Q42026-07-300.0900.057-0.052225.3212.353
2025Q32026-04-090.0900.058-0.078211.2204.494
2025Q22026-01-080.1000.063-0.073224.69207.714
2025Q12025-10-090.040-0.0740.167209.2203.095
2024Q42025-07-29-2.820-0.048-2.821225.46221.934
2024Q32025-04-09-0.050-0.018-0.051220.98224.14
2024Q22025-01-10-2.100-0.013-2.105231.3228.334
2024Q12024-10-10-0.060-0.033-0.058216.96215.053
2023Q42024-07-30-0.020-0.010-0.025236.79225.833
2023Q32024-04-09-0.0100.015-0.009228.8229.612
2023Q22024-01-09-0.0200.025-0.016229.63232.852
2023Q12023-10-100.0100.0250.007229231.12
2022Q42023-07-270.0300.0130.026241.81227.723
2022Q32023-03-300.040-0.0150.038218.26218.872
2022Q22023-01-05-0.190-0.080-0.194230.03228.31

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.5650.5580.563418.17421.26
2020FY0.5700.5900.568468.46463.34
2021FY0.4500.4250.447527.16526.7
2022FY-0.1200.080-0.121822.45808.35
2023FY-0.040-0.027-0.044924.22913.27
2024FY-5.030-2.228-5.035894.66891.13
2025FY0.3200.287-0.040870.4857.45
2026FY-0.333--888.08
2027FY-0.443--854.23
2028FY-0.600--906.87
2029FY-0.750--919.1
2030FY-0.540--995.6

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q2S2026-10-16404223.05222.2223.4
2026Q2S2026-10-13403224.75223.2229
2026Q2S2026-10-09413224.75223.2229
2026Q2S2026-10-07431226.98223.4229
2026Q2S2026-10-06430228.63226.7230
2026Q2S2026-09-25430228.63226.7230
2026Q2S2026-07-30430228.23226.7229
2026Q2S2026-06-23400222.48217.4228.4
2026Q2S2026-06-05402222.48217.4228.4
2026Q2S2026-05-04402222.98218228.4
2026Q2S2026-04-10502224.04218228.4
2026Q2S2026-04-09402223.53218228.4
2026Q2S2026-03-25300227.15221.2232.16
2026Q2S2026-03-24310227.15221.2232.16

Estimate history

EPS, annual0.6050.5740.5630.5680.447-0.121-0.044-5.035-0.036-0.2578
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.058-2.105-0.051-2.8210.167-0.073-0.078-0.052-0.055
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Sales, annual397.93414.186418.17468.459527.159822.447924.222894.661870.4883.99
Period201720182019202020212022202320242025TTM
Sales, quarterly216.964231.258220.98225.459209.189224.691211.2225.3222.8
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Shares, annual103.471104.433105.892107.468107.801216.246216.614217.044217.7218.3
Period201720182019202020212022202320242025MRQ
Shares, quarterly216.698216.944217.038217.044217.299217.526217.673217.7218.3
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue883.99870.40894.66924.22822.45527.16468.46418.17414.19
Cost of Goods Sold Incl. D&A556.81461.90473.29461.59416.49284.15253.40221.89222.27
Gross Profit327.18408.50421.38462.63405.95243.01215.06196.28191.92
Selling, General and Administrative Excl. Other327.14423.10411.96385.21368.44184.40140.89128.76123.83
Research and Development19.7618.4021.0922.4826.0417.0516.2514.7512.80
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income0.05-14.609.4277.4337.5258.6274.1767.5268.09
Interest Expense56.4557.6069.6875.6755.960.000.000.000.00
Unusual Expense7.987.801,071.8718.54-0.30-0.22-0.160.04-1.08
Net Income Before Taxes-67.66-9.00-1,133.11-14.30-22.0460.2175.2772.3172.96
Income Taxes-11.54-1.10-41.07-4.880.8311.9014.3912.8312.78
Consolidated Net Income-56.12-7.90-1,092.04-9.42-22.8748.3160.8859.4860.18
Net Income From Continuing Operations-56.12-7.90-1,092.04-9.42-22.8748.3160.8859.4860.18
Net Income-56.12-7.90-1,092.04-9.42-22.8748.3160.8859.4860.18
EPS (Recurring)-0.23-0.01-1.580.02-0.120.450.570.560.57
EPS (Basic, Before Extraordinaries)-0.26-0.04-5.03-0.04-0.120.450.570.570.58
EPS (Diluted)-0.26-0.04-5.03-0.04-0.120.450.570.560.57
EBITDA117.67107.20135.09198.65125.8982.3195.2185.9285.72
Non-Operating Income (Expense)-3.2971.00-0.972.48-3.901.370.944.823.78
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.1910.5913.6610.888.047.154.704.724.05
Price To Earnings Ratio-----59.1880.1363.7649.20
Price To Sales Ratio2.852.241.423.084.025.4210.559.007.13
Gross Margin37.0146.9347.1050.0649.3646.1045.9146.9446.34
Operating Margin0.01-1.681.058.384.5611.1215.8316.1516.44
Net Margin-6.35-0.91-122.06-1.02-2.789.1613.0014.2214.53
Shares Outstanding218.30217.70217.04216.61216.25107.80107.47105.89104.43
Market Capitalization2,532.352,532.351,271.842,848.403,781.712,862.604,939.623,768.312,942.40

Income statement, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q2
Total Revenue222.80225.30211.20224.69209.19225.46220.98231.26
Cost of Goods Sold Incl. D&A140.30140.60135.00140.91137.22156.12134.01141.53
Gross Profit82.5084.7076.2083.7871.9769.3486.9789.73
Selling, General and Administrative Excl. Other83.5081.5079.1083.0488.0677.2174.9872.66
Research and Development6.504.903.804.565.126.314.475.11
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.003.20-2.900.75-16.09-7.8711.9917.07
Interest Expense13.8013.9013.9014.8516.4417.1317.7418.14
Unusual Expense1.100.100.406.38-0.13603.176.52474.20
Net Income Before Taxes-14.90-12.10-20.30-20.3643.81-631.20-9.73-476.57
Income Taxes-3.00-0.80-3.30-4.447.47-19.011.23-20.29
Consolidated Net Income-11.90-11.30-17.00-15.9236.34-612.20-10.96-456.28
Net Income From Continuing Operations-11.90-11.30-17.00-15.9236.34-612.20-10.96-456.28
Net Income-11.90-11.30-17.00-15.9236.34-612.20-10.96-456.28
EPS (Recurring)-0.05-0.05-0.08-0.050.17-0.88-0.03-0.57
EPS (Basic, Before Extraordinaries)-0.05-0.05-0.08-0.070.17-2.82-0.05-2.10
EPS (Diluted)-0.05-0.05-0.08-0.070.17-2.82-0.05-2.10
EBITDA29.4032.6026.0029.6812.9622.3941.3647.12
Non-Operating Income (Expense)1.00-1.30-3.100.1276.21-3.032.54-1.30
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.452.370.953.433.923.423.293.81
Price To Sales Ratio2.852.242.811.481.411.422.413.36
Gross Margin37.0337.5936.0837.2934.4030.7539.3538.80
Operating Margin-0.451.42-1.370.33-7.69-3.495.427.38
Net Margin-5.34-5.02-8.05-7.0917.37-271.53-4.96-197.30
Shares Outstanding218.30217.70217.67217.53217.30217.04217.04216.94
Market Capitalization2,532.351,952.532,442.821,299.451,248.931,271.842,180.293,072.78

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments185.50129.00170.94245.57381.05381.09343.67267.52210.81
Short Term Receivables146.80153.38173.00153.2599.6791.8284.6882.5879.09
Inventories144.30190.86189.27133.81122.31100.7095.0585.9976.00
Other Current Assets128.00103.6956.0253.3023.7617.8414.0013.439.89
Total Current Assets604.60576.94589.23585.93626.80591.45537.41449.53375.79
Net Property, Plant & Equipment346.40356.28291.89210.68113.77102.9380.6274.8573.07
Total Investments and Advances0.000.000.230.000.000.000.000.000.00
Intangible Assets2,365.202,475.393,647.283,742.60250.21223.79176.92171.36169.15
Deferred Tax Assets63.7041.5335.3319.396.933.883.543.933.97
Other Assets13.9035.2320.2015.222.162.022.230.000.00
Total Assets3,393.803,485.374,584.164,573.82999.86924.07800.72699.67621.98
Short Term Debt Incl. Current Port. of LT Debt4.7024.947.553.281.441.281.050.000.00
Accounts Payable79.1079.6183.0676.6734.6123.9025.6519.0620.75
Income Tax Payable7.205.6010.456.952.131.851.460.600.17
Other Current Liabilities67.2063.8753.2758.5839.6626.5720.3318.5917.77
Total Current Liabilities158.20174.01154.32145.4777.8453.6048.4938.2538.69
Long Term Debt807.30887.67898.69894.250.000.000.000.000.00
Provision for Risks Charges0.800.820.820.820.820.620.820.820.82
Deferred Tax Liabilities305.40322.44362.05372.8123.9425.7921.6619.5518.08
Other Liabilities29.2029.1824.1426.259.883.684.573.164.23
Total Liabilities1,300.901,414.111,440.021,439.60112.4883.6975.5461.7761.81
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity2,092.902,071.253,144.143,134.22887.37840.38725.18637.90560.17
Total Shareholders Equity2,092.902,071.253,144.143,134.22887.37840.38725.18637.90560.17
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity2,092.902,071.253,144.143,134.22887.37840.38725.18637.90560.17
Total Liabilities & Stockholders Equity3,393.803,485.374,584.164,573.82999.86924.07800.72699.67621.98
Book Value Per Share9.619.5414.5114.498.237.826.856.115.41
Tangible Book Value Per Share-1.25-1.86-2.32-2.815.915.745.184.473.78
Full-Time Employees2,6362,9742,9172,6402,1081,8411,7641,6821,546
Price to Book Ratio1.210.480.911.213.216.125.294.616.99
Return on Assets-0.23-27.07-0.21-0.825.027.067.939.1110.91
Return on Equity-0.38-41.88-0.30-1.145.597.788.7310.0512.24
Return on Invested Capital-0.27-36.91-0.23-0.575.447.248.209.4311.27
Quick Ratio2.912.222.593.116.489.169.129.507.75
Current Ratio3.823.323.824.038.0511.0311.0811.759.71

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-56.14-7.90-1,092.04-9.42-22.8748.3160.8859.4860.18
Depreciation123.25121.90125.67121.2388.3823.6921.0418.4017.62
Other Funds (Non Cash)16.28-58.601,086.3123.0317.547.156.446.475.54
Funds from Operations59.7231.1062.16107.4163.8174.4687.7285.9484.54
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital25.5352.10-5.93-72.68-22.79-6.42-6.63-0.06-20.70
Cash from Operating Activities85.2583.2056.2334.7341.0368.0481.0985.8863.84
Capital Expenditures-35.50-51.30-104.59-111.42-65.76-24.43-26.71-24.05-14.66
Net Assets From Acquisitions0.000.000.000.0011.72-38.74-50.77-13.16-6.39
Sale of Fixed Assets and Businesses0.07121.805.080.110.830.000.000.000.00
Purchase or Sale of Investments0.000.000.3382.00254.25-34.05-28.08-51.57-98.10
Purchase of Investments0.000.000.000.00-12.52-415.89-792.68-458.30-437.32
Sale Or Maturity of Investments0.000.000.3382.00266.77381.84764.60406.73339.23
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-35.4270.50-99.19-29.31201.04-97.23-105.56-88.78-119.15
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock2.901.602.242.461.207.9334.6329.4113.90
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00-3.13
Sale of Common Pref Stock2.901.602.242.461.207.9334.6329.4117.03
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-20.02-100.10-0.320.00-119.280.000.000.000.00
Change in Long Term Debt-20.02-100.10-0.320.000.000.000.000.000.00
Issuance of Long Term Debt0.000.00550.000.000.000.000.000.000.00
Reduction of Long Term Debt-20.02-100.10-550.320.000.000.000.000.000.00
Net Financing Active Other Cash Flow-1.88-0.90-1.500.000.00-1.12-1.090.000.00
Other Financing Activities Uses-1.88-0.90-1.500.000.00-1.12-1.090.000.00
Cash from Financing Activities-19.01-99.400.422.46-118.086.8133.5429.4113.90
Exchange Rate Effect2.312.200.94-0.50-5.22-8.750.26-1.920.02
Net Change in Cash33.1256.50-41.617.37118.77-31.139.3324.58-41.39
Free Cash Flow49.7531.90-48.37-76.69-24.7343.6154.3861.8349.18
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow50.6861.16---65.5490.9260.8960.07
Deferred Taxes & Investment Tax Credit--24.30-57.78-27.42-19.23-4.70-0.641.601.20

Balance sheet, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Cash & Short Term Investments172.00185.50159.90145.34138.88129.00
Short Term Receivables136.20146.80137.10132.00138.46153.38
Inventories146.10144.30161.70162.77193.41190.86
Other Current Assets128.20128.00131.30134.4753.30103.69
Total Current Assets582.50604.60590.00574.58524.06576.94
Net Property, Plant & Equipment348.90346.40347.60347.46362.89356.28
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets2,343.402,365.202,389.602,405.422,455.032,475.39
Deferred Tax Assets-63.70---41.53
Other Assets28.4013.9031.8032.5036.1835.23
Total Assets3,303.203,393.803,359.003,359.953,378.163,485.37
Short Term Debt Incl. Current Port. of LT Debt0.004.700.000.000.0024.94
Accounts Payable77.6079.1075.2063.0476.6079.61
Income Tax Payable8.707.209.908.969.455.60
Other Current Liabilities63.2067.2065.5075.0560.1663.87
Total Current Liabilities149.50158.20150.60147.05146.21174.01
Long Term Debt774.20807.30793.30792.93792.53887.67
Provision for Risks Charges0.800.800.000.000.820.82
Deferred Tax Liabilities251.40305.40269.20273.95277.25322.44
Other Liabilities40.9029.2043.5041.5442.7029.18
Total Liabilities1,216.801,300.901,256.601,255.461,259.511,414.11
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity2,086.402,092.902,102.402,104.492,118.652,071.25
Total Shareholders Equity2,086.402,092.902,102.402,104.492,118.652,071.25
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity2,086.402,092.902,102.402,104.492,118.652,071.25
Total Liabilities & Stockholders Equity3,303.203,393.803,359.003,359.953,378.163,485.37
Book Value Per Share9.569.619.669.679.759.54
Tangible Book Value Per Share-1.18-1.25-1.32-1.38-1.55-1.86
Full-Time Employees-2,636---2,974
Price to Book Ratio1.210.931.160.610.600.48
Return on Assets-1.68-0.23-16.46-16.26-26.47-27.07
Return on Equity-2.67-0.38-25.56-25.25-39.71-41.88
Return on Invested Capital-0.42-0.39-0.59-0.551.25-20.69
Quick Ratio2.922.912.842.802.262.22
Current Ratio3.903.823.923.913.583.32

Cash flow, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Net Income-11.90-11.30-17.01-15.9236.34-612.20
Depreciation30.4035.0028.9228.9329.0536.45
Other Funds (Non Cash)4.704.502.045.04-70.18600.13
Funds from Operations18.0019.409.6712.64-10.62-0.29
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-5.1010.8013.036.8021.4714.81
Cash from Operating Activities12.9030.2022.7019.4410.8514.52
Capital Expenditures-8.20-4.00-11.63-11.67-24.00-16.14
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.070.00121.730.21
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-8.20-4.00-11.56-11.6797.72-15.93
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock2.20-0.100.82-0.030.910.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.20-0.100.82-0.030.910.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-20.000.00-0.030.00-100.08-0.32
Change in Long Term Debt-20.000.00-0.030.00-100.08-0.32
Issuance of Long Term Debt0.000.000.000.000.00550.00
Reduction of Long Term Debt-20.000.00-0.030.00-100.08-550.32
Net Financing Active Other Cash Flow-1.20-0.20-0.05-0.42-0.22-0.02
Other Financing Activities Uses-1.20-0.20-0.05-0.42-0.22-0.02
Cash from Financing Activities-19.00-0.300.74-0.45-99.39-0.09
Exchange Rate Effect0.80-0.302.67-0.870.692.80
Net Change in Cash-13.5025.6014.566.469.881.30
Free Cash Flow4.7026.2011.077.78-13.15-1.61
Price to Free Cash Flow50.6861.22598.10---

Revenue breakdown

Animal Care and Other2024: 34.70M 2025: 29.30M
Bacterial and General Sanitation2024: 164.80M 2025: 175.40M
Genomics Services2024: 89.20M 2025: 92.20M
Indicator Testing And Culture Media2024: 312.20M 2025: 332.70M
Life Sciences2024: 6.50M 2025: 6.60M
Natural Toxins And Allergens2024: 77.00M 2025: 77.50M
Other2024: 13.70M 2025: 12.70M
Rodenticides Insecticides and Disinfectants2024: 135.10M 2025: 87.10M
Veterinary Instruments and Disposables2024: 61.50M 2025: 56.90M
Non-US2024: 448.70M 2025: 445.30M
United States2024: 446.00M 2025: 425.10M
Animal Safety2024: 256.60M 2025: 229.30M
Food Safety2024: 638.10M 2025: 641.10M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.88%12.7M216.2M3.33M
2026-10-155.52%11.9M216.2M3.22M
2026-09-305.48%11.8M216.0M2.66M
2026-09-155.17%11.2M216.0M2.09M
2026-08-314.90%10.6M216.0M1.99M
2026-08-144.60%9.9M215.9M2.31M
2026-07-314.36%9.4M216.2M2.24M
2026-07-155.00%10.8M215.8M2.27M
2026-06-304.86%10.5M215.8M2.56M
2026-06-155.61%11.9M212.5M2.53M
2026-05-296.04%13.0M215.8M2.71M
2026-05-154.97%10.7M215.8M2.56M
2026-04-305.14%11.1M215.8M2.81M
2026-04-154.65%10.0M215.9M2.95M
2026-03-314.67%10.1M215.7M3.40M
2026-03-134.18%9.0M215.7M3.47M
2026-02-274.59%9.9M215.7M3.76M
2026-02-134.85%10.5M215.7M3.91M
2026-01-305.50%11.9M215.7M3.90M
2026-01-156.53%14.1M215.8M3.90M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.508.6010.709.2517.0240.000.000.989-0.0160.001
call5.006.108.207.109.0680.000.000.967-0.0270.001
call7.503.705.404.605.0930.000.000.926-0.0320.003
call10.001.002.452.151.84718.000.000.785-0.0430.005
call12.500.000.500.051.1705680.000.368-0.0430.007
call15.000.000.750.752.05134.000.000.260-0.0680.006
call17.500.000.750.102.6740.000.000.218-0.0810.005
call20.000.000.750.003.1650.000.000.195-0.0890.005
call22.500.000.050.432.9361.000.000.115-0.0580.004
put2.500.000.050.005.7510.000.00-0.018-0.0240.001
put5.000.000.150.003.4560.000.00-0.033-0.0260.001
put7.500.000.150.052.1965.000.00-0.074-0.0310.003
put10.000.000.350.041.41519.000.00-0.215-0.0420.005
put12.500.851.100.950.73052.005.00-0.632-0.0420.007
put15.003.003.703.401.7150.002.00-0.740-0.0670.006
put17.505.006.500.002.8860.000.00-0.782-0.0790.005
put20.007.508.900.003.2030.000.00-0.805-0.0870.005
put22.5010.0011.400.003.6160.000.00-0.964-0.0150.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-303Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-28144Filing for proposed sale of securities under Rule 144.SEC
2026-10-268-K/A2026-10-01SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-233Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-213Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-213Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-213Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-20S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-10-20S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-08-31SEC
2026-10-078-KCurrent report2026-10-01SEC
2026-10-068-KCurrent report2026-10-06SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100114.68K1
2026-106.03K100
2026-090000
2026-084.37K100
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-02492200
2026-011.53K200
2025-120000
2025-111.11K100

Institutional holders

Manager% owned
BlackRock, Inc.15.36%
Neuberger Berman Group LLC7.61%
VANGUARD PORTFOLIO MANAGEMENT LLC5.99%
DIMENSIONAL FUND ADVISORS LP4.72%
VANGUARD CAPITAL MANAGEMENT LLC4.44%
SG Americas Securities, LLC4.30%
T. Rowe Price Investment Management, Inc.4.29%
STATE STREET CORP4.11%
Gates Capital Management, Inc.4.02%
ING GROEP NV4.01%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF6.03%
Neuberger Genesis Fund3.44%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.18%
iShares Russell 2000 ETF2.65%
BARON SMALL CAP FUND2.30%
VANGUARD SMALL-CAP INDEX FUND2.29%
VANGUARD SMALL-CAP VALUE INDEX FUND1.45%
U.S. SMALL CAP VALUE PORTFOLIO1.35%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Small Cap Index Fund1.11%

OakChart. NEOG. Cached 15 minutes.